Search results for "p24"

showing 10 items of 182 documents

Legionella pneumophila pangenome reveals strain-specific virulence factors

2010

Abstract Background Legionella pneumophila subsp. pneumophila is a gram-negative γ-Proteobacterium and the causative agent of Legionnaires' disease, a form of epidemic pneumonia. It has a water-related life cycle. In industrialized cities L. pneumophila is commonly encountered in refrigeration towers and water pipes. Infection is always via infected aerosols to humans. Although many efforts have been made to eradicate Legionella from buildings, it still contaminates the water systems. The town of Alcoy (Valencian Region, Spain) has had recurrent outbreaks since 1999. The strain "Alcoy 2300/99" is a particularly persistent and recurrent strain that was isolated during one of the most signifi…

Genomic Islandslcsh:QH426-470biologyVirulence FactorsLegionellalcsh:BiotechnologyStrain (biology)OutbreakVirulenceGenomicsbiology.organism_classificationLegionella pneumophilaGenomeLegionella pneumophilaMicrobiologyEvolution Molecularlcsh:Geneticslcsh:TP248.13-248.65Horizontal gene transferGeneticsCRISPRGenome BacterialResearch ArticleBiotechnologyBMC Genomics
researchProduct

Rapid adaptation of signaling networks in the fungal pathogen Magnaporthe oryzae

2019

Abstract Background One fundamental question in biology is how the evolution of eukaryotic signaling networks has taken place. “Loss of function” (lof) mutants from components of the high osmolarity glycerol (HOG) signaling pathway in the filamentous fungus Magnaporthe oryzae are viable, but impaired in osmoregulation. Results After long-term cultivation upon high osmolarity, stable individuals with reestablished osmoregulation capacity arise independently from each of the mutants with inactivated HOG pathway. This phenomenon is extremely reproducible and occurs only in osmosensitive mutants related to the HOG pathway – not in other osmosensitive Magnaporthe mutants. The major compatible so…

GlycerolMagnaportheved/biology.organism_classification_rank.speciesMutantGenomeSalt StressTranscriptome0302 clinical medicineOsmoregulationLoss of Function MutationGene Expression Regulation FungalGene Regulatory NetworksSuppressorReestablishment of osmoregulation0303 health sciencesbiologyMagnaporthe oryzaeRewiringAdaptation PhysiologicalRapid adaptationCell biologyMagnaportheOsmoregulationEpigeneticsGenome FungalBiotechnologySignal TransductionResearch Articlelcsh:QH426-470lcsh:BiotechnologyDioxolesFungal Proteins03 medical and health sciencesDrug Resistance Fungallcsh:TP248.13-248.65GeneticsPyrrolesModel organismGene030304 developmental biologyPlant DiseasesOsmotic concentrationved/biologyGene Expression ProfilingEvolution of signaling networksHOG pathwayOryzabiology.organism_classificationlcsh:Genetics030217 neurology & neurosurgery
researchProduct

Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative pers…

1998

/ T cells responding to HIV-1 peptides were observed in none of 11 HIV- seronegative donors without a history of HIV exposure. ELISPOT assays are relatively fast and easy to perform and appear to reliably detect T cell reactivity due to previous exposure to HIV. These findings support the use of the ELISPOT assay for monitoring T cell responsiveness to HIV peptides. In acute infection with the human immunodeficiency virus We described recently an enzyme-linked immunospot (ELISPOT) assay to detect and quantitate single blood-de- type 1 (HIV-1), initial reduction in virus load is associated with the appearance of a high frequency of antiviral cytotoxic T rived CD8 / T lymphocytes forming tumo…

HIV AntigensT cellHIV Core Protein p24HIV InfectionsBiologyCD8-Positive T-LymphocytesHLA-A3 AntigenVirusAntigenRisk FactorsHLA-A2 AntigenmedicineImmunology and AllergyCytotoxic T cellHumansAntigen PresentationELISPOTT lymphocytebiology.organism_classificationVirologyHIV Reverse TranscriptaseInfectious Diseasesmedicine.anatomical_structureImmunologyLentivirusPeptidesCD8The Journal of infectious diseases
researchProduct

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors

2010

The human genome is epigenetically organized through a series of modifications to the histone proteins that interact with the DNA. In cancer, many of the proteins that regulate these modifications can be altered in both function and expression. One example of this is the family of histone deacetylases (HDACs), which as their name implies remove acetyl groups from the histone proteins, allowing for more condensed nucleosomal structure. HDACs have increased expression in cancer and are also believed to promote carcinogenesis through the acetylation and interaction with key transcriptional regulators. Given this, small molecule histone deacetylases inhibitors have been identified and developed…

Health Toxicology and Mutagenesislcsh:Biotechnologylcsh:MedicineReview ArticleNeoplasmslcsh:TP248.13-248.65GeneticsAnimalsHumansCancer epigeneticsMolecular BiologyHistone deacetylase 5biologyHDAC11Histone deacetylase 2HDAC10lcsh:RGeneral MedicineHistone Deacetylase InhibitorsHistoneBiochemistryAcetylationHematologic Neoplasmsbiology.proteinCancer researchMolecular MedicineHistone deacetylaseBiotechnologyJournal of Biomedicine and Biotechnology
researchProduct

Artificial Chromosomes to Explore and to Exploit Biosynthetic Capabilities of Actinomycetes

2012

Actinomycetes are an important source of biologically active compounds, like antibiotics, antitumor agents, and immunosuppressors. Genome sequencing is revealing that this class of microorganisms has larger genomes relative to other bacteria and uses a considerable fraction of its coding capacity (5–10%) for the production of mostly cryptic secondary metabolites. To access actinomycetes biosynthetic capabilities or to improve the pharmacokinetic properties and production yields of these chemically complex compounds, genetic manipulation of the producer strains can be performed. Heterologous expression in amenable hosts can be useful to exploit and to explore the genetic potential of actinom…

Heterologous expression.DNA BacterialHealth Toxicology and Mutagenesislcsh:BiotechnologyHeterologouslcsh:MedicineHuman artificial chromosomeReview ArticleSettore BIO/19 - Microbiologia GeneraleStreptomycesGenomeMicrobial biotechnologyDNA sequencingSecondary metabolite03 medical and health scienceslcsh:TP248.13-248.65GeneticsChromosomes ArtificialMolecular BiologyGene030304 developmental biologyGene LibraryGenetics0303 health sciencesbiology030306 microbiologyActinomycetelcsh:RGeneral Medicinebiology.organism_classificationArtificial chromosomeBiosynthetic PathwaysActinobacteriaMultigene FamilyMolecular MedicineHeterologous expressionBacteriaBiotechnologyJournal of Biomedicine and Biotechnology
researchProduct

Injectable Hydrogel for Synergetic Low Dose Radiotherapy, Chemodynamic Therapy and Photothermal Therapy

2021

Higher doses of radiotherapy (RT) are associated with resistance induction, therefore highly selective and controllable radiosensitizers are urgently needed. To address this issue, we developed a FeGA-based injectable hydrogel system (FH) that can be used in combination with low-dose radiation. Our FH can deliver FeGA directly to the tumor site via intratumoral injection, where it is a reservoir-based system to conserve FeGA. The photothermal properties of FeGA steadily dissolve FH under laser irradiation, and, simultaneously, FeGA reacts with a large amount of H2O2 in the cell to produce OH (Fenton reaction) which is highly toxic to mitochondria, rendering the cell inactive and reducing ra…

HistologyChemistryfenton reactionmedicine.medical_treatmentTherapeutic effectCellBiomedical EngineeringBioengineering and BiotechnologyTumor therapyBioengineeringPhotothermal therapyIn vitroRadiation therapyFeGamedicine.anatomical_structureIn vivoCancer researchmedicineIrradiationhydrogeltumor therapyTP248.13-248.65radiotherapyOriginal ResearchBiotechnologyFrontiers in Bioengineering and Biotechnology
researchProduct

Smart materials meet multifunctional biomedical devices:Current and prospective implications for nanomedicine

2017

With the increasing advances in the fabrication and in monitoring approaches of nanotechnology devices, novel materials are being synthesized and tested for the interaction with biological environments. Among them, smart materials in particular provide versatile and dynamically tunable platforms for the investigation and manipulation of several biological activities with very low invasiveness in hardly accessible anatomical districts. In the following, we will briefly recall recent examples of nanotechnology-based materials that can be remotely activated and controlled through different sources of energy, such as electromagnetic fields or ultrasounds, for their relevance to both basic scien…

HistologyComputer scienceMini Reviewlcsh:BiotechnologyBiomedical EngineeringBioengineeringNanotechnology02 engineering and technology010402 general chemistrySmart materialRemote stimulation01 natural sciencesdrug delivery; immune system; remote stimulation; smart materials; tissue engineeringlcsh:TP248.13-248.65Tissue engineeringSmart materialsBioengineering and Biotechnologyremote stimulation021001 nanoscience & nanotechnology0104 chemical sciencesimmune systemTissue targetingImmune systemsmart materialstissue engineeringdrug deliveryDrug deliveryNanomedicine0210 nano-technologyBiotechnology
researchProduct

What Symbionts Teach us about Modularity

2013

The main goal of Synthetic Biology is to apply engineering principles to biotechnology in order to make life easier to engineer. These engineering principles include modularity: decoupling of complex systems into smaller, orthogonal subsystems that can be used in a range of different applications. The successful use of modules in engineering is expected to be reproduced in synthetic biological systems. But the difficulties experienced up to date with synthetic biology approaches question the short-term feasibility of designing life. Considering the “engineerable” nature of life, here we discuss the existence of modularity in natural living systems, particularly in symbiotic interactions, an…

HistologyOrthogonality (programming)Computer scienceSystems biologylcsh:BiotechnologyBiomedical EngineeringComplex systemBioengineeringSynthetic biologyendosymbiontsorthogonalitylcsh:TP248.13-248.65Similarity (psychology)modularityModularity (networks)business.industryBioengineering and Biotechnologysystems biologyiGEMsymbiosisBiotechnologyLiving systemsRange (mathematics)Perspective ArticlebusinessSoftware engineeringBiotechnologyFrontiers in bioengineering and biotechnology
researchProduct

Obsolescence and intervention: on synthetic-biological entities.

2014

Oftentimes, topics that might fall outside of science’s remit seem to end up becoming a part of it, sooner or later. This appears to be the case of synthetic biology, a new biological science (although some maintain that it is a form of engineering, or treat it as such; Endy, 2005), which seems to have become essential to the understanding of living beings and their extreme manipulation. I believe it to be a new form of biology. In truth, synthetic biology has a long history and, conceptually speaking, may well have formed part of the interests and research efforts of our illustrious predecessors throughout the first half of the twentieth century and even earlier. In any event, and broadly …

Histologybusiness.industryComputer sciencelcsh:BiotechnologyEvent (relativity)Biomedical EngineeringBioengineering and Biotechnologynatural entitiesBioengineeringEnvironmental ethicsOpinion ArticleBiotechnologySynthetic biologyIntervention (law)Obsolescencelcsh:TP248.13-248.65evolutionartificial entitiesState of the sciencebusinessmetabolismmachinesBiotechnologyFrontiers in bioengineering and biotechnology
researchProduct

Activation of Human Osteoblasts via Different Bovine Bone Substitute Materials With and Without Injectable Platelet Rich Fibrin in vitro

2021

IntroductionThe aim of the in vitro study was to compare the effect of four bovine bone substitute materials (XBSM) with and without injectable platelet-reach fibrin for viability and metabolic activity of human osteoblasts (HOB) as well as expression of alkaline phosphatase (ALP), bone morphogenetic protein 2 (BMP-2), and osteonectin (OCN).Materials and MethodsCerabone® (CB), Bio-Oss® (BO), Creos Xenogain® (CX) and MinerOss® X (MO) ± i-PRF were incubated with HOB. At day 3, 7, and 10, cell viability and metabolic activity as well as expression of ALP, OCN, and BMP-2, was examined.ResultsFor non-i-PRF groups, the highest values concerning viability were seen for CB at all time points. Pre-t…

Histologyplatelet rich fibrin (PRF)proliferationlcsh:BiotechnologyBiomedical EngineeringBioengineering02 engineering and technologyBone morphogenetic protein 2vitalityFibrinAndrology03 medical and health sciences0302 clinical medicinelcsh:TP248.13-248.65medicineViability assaybovine boneOriginal ResearchbiologyChemistryBioengineering and Biotechnologyin vitroOsteoblastbone substitute030206 dentistry021001 nanoscience & nanotechnologydigestive system diseasesPlatelet-rich fibrinIn vitroPCRmedicine.anatomical_structureosteoblastbiology.proteinAlkaline phosphataseOsteonectin0210 nano-technologyBiotechnologyFrontiers in Bioengineering and Biotechnology
researchProduct